Clinical Evaluation and Cost-Effectiveness Analysis of Serum Tumor Markers in Lung Cancer
Figure 1
Receiver operation characteristic curves (ROCs) for the tumor markers in serum for the discrimination between lung cancer and healthy control. SCCA (95% CI 0.427~0.728), NSE 0. (95% CI 0.861~0.994), CEA (95% CI 0.905~1.008), and CYFRA21-1 (95% CI 0.919~1.01).
